Carregant...
Biomaterial-facilitated Immunotherapy for Established Oral Cancers
We evaluated a peptide-based immunotherapy termed SynerGel: an injectable, biomaterial-based platform for intratumoral drug delivery. A drug-mimicking peptide hydrogel named L-NIL-MDP was loaded with an anti-tumor cyclic dinucleotide (CDN) immunotherapy agonist. The biomaterial combines inducible Ni...
Guardat en:
| Publicat a: | ACS Biomater Sci Eng |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8325389/ https://ncbi.nlm.nih.gov/pubmed/33470801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsbiomaterials.0c01575 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|